tiprankstipranks
Trending News
More News >
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market

Aarti Drugs Limited (AARTIDRUGS) Income Statement

Compare
3 Followers

Aarti Drugs Limited Income Statement

Last quarter (Q4 2025), Aarti Drugs Limited's total revenue was ₹6.77B, an increase of 9.16% from the same quarter last year. In Q4, Aarti Drugs Limited's net income was ₹628.60M. See Aarti Drugs Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 23.87B₹ 25.09B₹ 27.16B₹ 24.89B₹ 21.55B
Gross Profit
₹ 8.45B₹ 3.51B₹ 8.28B₹ 5.04B₹ 6.00B
Operating Expenses
₹ 1.12B₹ 1.17B₹ 5.72B₹ 2.06B₹ 2.05B
Depreciation and Amortization
₹ 557.80M₹ 514.47M₹ 503.24M₹ 500.49M₹ 498.83M
EBITDA
₹ 2.87B₹ 3.20B₹ 3.12B₹ 3.44B₹ 4.45B
Operating Income
₹ 7.33B₹ 2.78B₹ 2.57B₹ 2.88B₹ 3.88B
Other Income/Expenses
₹ -5.21B₹ -421.76M₹ -406.37M₹ -171.55M₹ -251.25M
Pretax Income
₹ 2.12B₹ 2.36B₹ 2.24B₹ 2.70B₹ 3.69B
Net Income
₹ 1.68B₹ 1.71B₹ 1.66B₹ 2.05B₹ 2.80B
Per Share Metrics
Basic EPS
₹ 18.35₹ 18.56₹ 17.96₹ 22.14₹ 30.09
Diluted EPS
₹ 18.35₹ 18.65₹ 17.96₹ 22.14₹ 30.09
Weighted Average Shares Outstanding
91.64M 92.36M 92.60M 92.60M 93.20M
Weighted Average Shares Outstanding (Diluted)
91.64M 91.94M 92.60M 92.60M 93.20M
Currency in INR

Aarti Drugs Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis